Webinar February 24, 2021 – Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule

On February 24, LAB150 together with TIAP hosts a webinar entitled Adventures in Drug Hunting: Identify and Advance Your Drug-Like Molecule. Please see the link below for more information and to register.  There are limited number of openings, so please register soon. Feel free to circulate to senior…

Project 7: Novel Therapeutic Agent for Immuno-Oncology from Sunnybrook Research Institute

Toronto, Ontario, June 04, 2020 (GLOBE NEWSWIRE) — Toronto Innovation Acceleration Partners (TIAP) announced today the launch of a new LAB150 project aimed at developing a novel therapeutic agent for immuno-oncology. The research for the promising new approach comes from Dr. Jean GariĆ©py and his…

Funding for Sinai Health Netherton Syndrome project from partners Evotec and AmorChem

Funding for Sinai Health Netherton Syndrome project from partners Evotec and AmorChem

TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — Toronto Innovation Acceleration Partners (TIAP), Evotec SE and AmorChem II Fund L.P. (AmorChem) are pleased to announce a $1.75M investment into a drug development project focused on a rare skin disease called Netherton Syndrome, that affects one in…

Two New Projects: Cystic Fibrosis and Respiratory Syncytial Virus

Two New Projects: Cystic Fibrosis and Respiratory Syncytial Virus

Toronto, ON, Feb. 27, 2019 (GLOBE NEWSWIRE) — MaRS Innovation announced today the concurrent launch of two new LAB150 projects. These projects build on breakthroughs in disease-focused scientific research by prominent teams at The Hospital for Sick Children (SickKids) and the University of Toronto, both…